News

October 9, 2018 American College of Gastroenterology (ACG) 2018 IBS Monograph Reaffirms the Preceding ACG 2014 IBS Monograph’s Support for Peppermint Oil’s use in IBS but Qualifies it With the Need for More Distal Delivery.

Read More

October 9, 2018 Twenty-Four Month, Post-Marketing Safety Surveillance Data Presented at the American College of Gastroenterology (ACG) Annual Meeting Further Confirms Favorable Safety and Tolerability Profile for IBgard®

Read More

August 13, 2018
IM HealthScience® (IMH) today announced that IBgard®, the clinically studied, nonprescription natural health product containing peppermint oil for helping in the relief and improvement of Irritable Bowel Syndrome (IBS) symptoms, has gained the Canadian Digestive Health Foundation’s CDHF Certified Symbol of Distinction designation.

Read More

April 20, 2018 Real-World Data From Surveillance Study Confirms Excellent Safety and Tolerability Profile of IBgard® At 24 Months

Read More

October 30, 2017 Final Results of Real-world Data From Surveillance Study Confirm High Levels of Patient Satisfaction and Rapid Irritable Bowel Syndrome (IBS) Symptom Improvement With Non-Prescription IBgard® for the Third Year in a Row, U.S. Gastroenterologists Endorse Clinically Studied, Non-Prescription IBgard ® for Irritable Bowel Syndrome (IBS), by Overwhelming Margin

Read More

September 25, 2017 Global, Peer-Reviewed Medical Journal Publishes Results of a First-ever Data Analysis in Irritable Bowel Syndrome (IBS) Patients With Mixed Diarrhea and Constipation (IBS-M), Demonstrating Effectiveness Of the Novel Delivery System of Peppermint Oil in IBgard

Read More

August 21, 2017 Caret Pharma to Acquire Fiber Choice®, a Line of Innovative Dietary Supplements Containing 100% Natural, Prebiotic Fiber

Read More

July 5, 2017 IBgard® featured on CBS News: Age Old Remedy Could Spell Relief for IBS

Read More

May 10, 2017 Additional Data Analysis From an IBS (Irritable Bowel Syndrome) Clinical Trial Demonstrate IBgard® Delivered Unprecedented Symptom Reduction in the Largest and Most Dissatisfied Group of IBS Patients

Read More

Access to this section is intended for Healthcare Practitioners only.

Please confirm below that you are a Healthcare Practitioner or click here to return to the consumer section of the site.

Confirm